The polymeric encapsulated form of curcumin induced anti-cancer activity in breast cancer (MDA-MB-231) and lung cancer (A549) cell lines by modulating the expression of hypoxia-inducing factors (HIF) and the p65 subunit (RelA) of the transcription factor, NF-κB. This evidence concerns the gene RELA and breast carcinoma.